Trending:
Protein analyzing biotechnology firm Somalogic Inc. (Nasdaq: SLGC) has inked a partnership deal with genomics company Illumina Inc. (Nasdaq: ILMN) to develop and bring to market a co-branded next-generation sequencing (NGS) platform to be used to better understand the human body.
Somalogic develops platforms to read thousands of proteins in a patient’s blood or urine sample that may signal illnesses or future health conditions and suggest potential treatments via machine learning.
“As part of the agreement, Illumina will develop and deploy NGS-based protein identification and measurement tools into laboratories worldwide, and facilitate the development and use of high-plex protein pattern recognition tests,” according to a company news release.
Terms of the deal were not disclosed.
“Proteins play a central role in cellular function and health, and NGS can support a greater understanding of this role by unlocking biological insights at scale,” Illumina chief technology officer Alex Aravanis said in a statement. “We are committed to increasing the utility of NGS, and our partnership with SomaLogic will enable existing and future NGS customers to conduct even more sophisticated, high throughput multiomic studies.”
© 2022 BizWest Media LLC
Sign up for email newsletters
Carpet Masters of Colorado is your source for one-stop flooring solutions in Longmont! They are locally owned and operated, serving…
It’s time for maintenance-free senior living at AltaVita Independent Living in Longmont! Residents enjoy top-notch services and amenities without the…
If you have been considering a new home in Aurora, you need to speak to Fred Smith, a Realtor who…
Cozy Country Care provides trusted caregivers for seniors in Northern Colorado.  The staff of vocational nurses, CNAs and personal caregivers…
Are you hosting a New Year’s party? Start at Your Butcher, Frank for all the best cuts of meat, specialty…

source